Fabio
115 lines
7.1 KiB
Markdown
115 lines
7.1 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Federal 340-B Drug Pricing Program; impacts within the Commonwealth."
|
||
description: "Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2026"
|
||
identifier: "SB 278"
|
||
citation: "Virginia SB 278 (2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Kannan Srinivasan"]
|
||
version_count: 7
|
||
action_count: 40
|
||
vote_count: 8
|
||
first_action: "2026-01-13"
|
||
last_action: "2026-04-13"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/26fec5d8-814d-4502-a490-e36dad19f65e"
|
||
source_url: "https://lis.virginia.gov/bill-details/20261/SB278"
|
||
source_hash: "8e268f60710a600020bf0a9549b05511113088208bd275372c0aeebc01ebf9bb"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia SB 278 (2026) — Federal 340-B Drug Pricing Program; impacts within the Commonwealth.
|
||
|
||
Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Introduced** (filed) — [source](https://lis.blob.core.windows.net/files/1087074.PDF)
|
||
2. **Education and Health Substitute** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1104898.PDF)
|
||
3. **Finance and Appropriations Substitute** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1145734.PDF)
|
||
4. **Health Subcommittee Amendment** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1178072.HTML)
|
||
5. **Health and Human Services Amendment** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1182005.HTML)
|
||
6. **House Amendments** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1190873.HTML)
|
||
7. **Enrolled** (enrolled) — [source](https://lis.blob.core.windows.net/files/1201105.PDF)
|
||
|
||
## Votes
|
||
|
||
- H VOTE: — **97–0** (pass) · lower
|
||
- Concur House Amendments R — **39–0** (pass) · upper
|
||
- Constitutional reading dispensed R — **40–0** (pass) · upper
|
||
- Reported from Education and Health with substitute — **9–0** (pass) · upper
|
||
- Passage R — **39–0** (pass) · upper
|
||
- Reported from Finance and Appropriations with substitute — **15–0** (pass) · upper
|
||
- Subcommittee recommends reporting with amendment(s) — **10–0** (pass) · lower
|
||
- Reported from Health and Human Services with amendment(s) — **21–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Kannan Srinivasan — primary (person)
|
||
- Barbara A. Favola — cosponsor (person)
|
||
- L. Louise Lucas — cosponsor (person)
|
||
- Lashrecse D. Aird — cosponsor (person)
|
||
- Rodney T. Willett — cosponsor (person)
|
||
- Saddam Azlan Salim — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-13** Prefiled and ordered printed; Offered 01-14-2026 26102079D `filing, introduction`
|
||
- **2026-01-13** Referred to Committee on Education and Health `referral-committee`
|
||
- **2026-01-20** Assigned Education sub: Health `referral-committee`
|
||
- **2026-01-27** Fiscal Impact Statement from Department of Planning and Budget (SB278)
|
||
- **2026-01-28** Senate subcommittee offered
|
||
- **2026-01-29** Senate committee offered
|
||
- **2026-01-29** Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A) `committee-passage`
|
||
- **2026-01-30** Committee substitute printed 26106505D-S1 `substitution`
|
||
- **2026-02-11** Reported from Finance and Appropriations with substitute (15-Y 0-N) `committee-passage`
|
||
- **2026-02-12** Rules suspended
|
||
- **2026-02-12** Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
|
||
- **2026-02-12** Passed by for the day Block Vote (Voice Vote)
|
||
- **2026-02-13** Committee substitute printed 26107756D-S2 `substitution`
|
||
- **2026-02-13** Read second time `reading-2`
|
||
- **2026-02-13** Committee substitute rejected (Voice Vote)
|
||
- **2026-02-13** Committee substitute agreed to (Voice Vote) `substitution`
|
||
- **2026-02-13** Engrossed by Senate - committee substitute (Voice Vote) `substitution`
|
||
- **2026-02-16** Read third time and passed Senate (39-Y 0-N 0-A) `passage, reading-3`
|
||
- **2026-02-19** Placed on Calendar
|
||
- **2026-02-19** Read first time `reading-1`
|
||
- **2026-02-19** Referred to Committee on Health and Human Services `referral-committee`
|
||
- **2026-02-23** Assigned sub: Health `referral-committee`
|
||
- **2026-02-23** Fiscal Impact Statement from Department of Planning and Budget (SB278)
|
||
- **2026-02-24** House subcommittee offered
|
||
- **2026-02-24** Subcommittee recommends reporting with amendment(s) (10-Y 0-N)
|
||
- **2026-02-26** Reported from Health and Human Services with amendment(s) (21-Y 0-N) `committee-passage`
|
||
- **2026-03-02** Read second time `reading-2`
|
||
- **2026-03-03** Read third time `reading-3`
|
||
- **2026-03-03** committee amendments agreed to `amendment-passage`
|
||
- **2026-03-03** Engrossed by House as amended
|
||
- **2026-03-03** Passed House with amendments (97-Y 0-N 0-A) `passage`
|
||
- **2026-03-05** House amendments agreed to by Senate (39-Y 0-N 0-A) `amendment-passage`
|
||
- **2026-03-11** Enrolled `enrolled`
|
||
- **2026-03-11** Bill text as passed Senate and House (SB278ER) `passage`
|
||
- **2026-03-11** Fiscal Impact Statement from Department of Planning and Budget (SB278)
|
||
- **2026-03-11** Signed by President `passage`
|
||
- **2026-03-12** Signed by Speaker `passage`
|
||
- **2026-03-14** Enrolled Bill communicated to Governor on March 14, 2026 `enrolled, executive-receipt`
|
||
- **2026-03-14** Governor's Action Deadline 11:59 p.m., April 13, 2026 `executive-receipt`
|
||
- **2026-04-13** Approved by Governor-Chapter 887 (effective 7/1/2026) `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/26fec5d8-814d-4502-a490-e36dad19f65e`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|